Regulatory compliance IT budgets in biotech companies to grow 5% next year

According to Life Science Insights (LSI), the portion of the pharma and biotech IT budget that is spent on addressing regulatory compliance needs will grow by 5% over the next 12 months. New and replacement investments in enterprise regulatory content management systems will be an important component of this spending.